Prognostic association of PTGS2 (COX-2)
over-expression according to BRAF mutation status in colorectal
cancer: results from two prospective cohorts and CALGB 89803 (Alliance)
trial
- Citation:
- Eur. J. Cancer vol 111 82-93
- Year:
- 2019
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Meta-Analysis
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pmc-release
- Note:
- Methodological:
- No
- Biospecimen:
- Yes
- SDC:
- No
- Book Volume:
- 8
- Parents:
- None
- Children:
- None
- Program:
- TRP
- Primary Committee:
- Correl Sci NOS
- Sec. Committees:
- Pharmas:
- Pfizer
- Grants:
- U10CA180821, U10CA180882, U10CA180791, U10CA180867, U24CA196171, P01 CA87969, UM1 CA186107, P01 CA55075, UM1 CA167552, P50 CA127003, R01 CA118553, R01 CA169141, R01 CA137178, K24 DK098311, R01 CA205406, R35 CA197735, R01 CA151993 to S.O., K07 CA190673, K07 CA188126, SU2C-AACR-DT22-17, JP2017-775
- Corr. Author:
- Authors:
- Keisuke Kosumi Tsuyoshi Hamada Sui Zhang Li Liu Annacarolina da Silva Hideo Koh Tyler S. Twombly Kosuke Mima Teppei Morikawa Mingyang Song Jonathan A. Nowak Reiko Nishihara Leonard B. Saltz Donna Niedzwiecki Fang-Shu Ou Tyler Zemla Robert J. Mayer Hideo Baba Kimmie Ng Marios Giannakis Xuehong Zhang Kana Wu Edward L. Giovannucci Andrew T. Chan Charles S. Fuchs Jeffrey A. Meyerhardt Shuji Ogino
- Networks:
- LAPS-CT018, LAPS-MA036, LAPS-MN026, LAPS-NY016
- Study
- Multiple Studies, or Legacy Studies in Alliance Study:
- CALGB-89803
- Phases:
- 3
- Keywords:
- adenocarcinoma, clinical outcome, colorectal neoplasm, immunity, immunology, inflammation, inflammatory mediator, molecular pathological epidemiology, precision medicine, prostaglandin, PTGS, RAF